Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estradiol- and Progesterone-Associated Changes in microRNA-Induced Silencing and Reduced Antiseizure Efficacy of an Antagomir in Female Mice.
Tiwari D, Rajathi V, Rymer JK, Beasley LN, McGann AM, Bunk AT, Parkins EV, Rice MF, Smith KE, Ritter DM, White AR, Doerning CM, Gross C. Tiwari D, et al. Among authors: white ar. eNeuro. 2023 Jul 24;10(7):ENEURO.0047-22.2023. doi: 10.1523/ENEURO.0047-22.2023. Print 2023 Jul. eNeuro. 2023. PMID: 37433683 Free PMC article.
Neurovascular Development in Pten and Tsc2 Mouse Mutants.
Dusing M, LaSarge CL, White A, Jerow LG, Gross C, Danzer SC. Dusing M, et al. eNeuro. 2023 Feb 23;10(2):ENEURO.0340-22.2023. doi: 10.1523/ENEURO.0340-22.2023. Print 2023 Feb. eNeuro. 2023. PMID: 36759189 Free PMC article.
GABAA Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome.
Schaefer TL, Ashworth AA, Tiwari D, Tomasek MP, Parkins EV, White AR, Snider A, Davenport MH, Grainger LM, Becker RA, Robinson CK, Mukherjee R, Williams MT, Gibson JR, Huber KM, Gross C, Erickson CA. Schaefer TL, et al. Among authors: white ar. Front Psychiatry. 2021 May 21;12:678090. doi: 10.3389/fpsyt.2021.678090. eCollection 2021. Front Psychiatry. 2021. PMID: 34093287 Free PMC article.
Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model.
Gross C, Banerjee A, Tiwari D, Longo F, White AR, Allen AG, Schroeder-Carter LM, Krzeski JC, Elsayed NA, Puckett R, Klann E, Rivero RA, Gourley SL, Bassell GJ. Gross C, et al. Among authors: white ar. Neuropsychopharmacology. 2019 Jan;44(2):324-333. doi: 10.1038/s41386-018-0150-5. Epub 2018 Jul 13. Neuropsychopharmacology. 2019. PMID: 30061744 Free PMC article.
Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model.
Gross C, Banerjee A, Tiwari D, Longo F, White AR, Allen AG, Schroeder-Carter LM, Krzeski JC, Elsayed NA, Puckett R, Klann E, Rivero RA, Gourley SL, Bassell GJ. Gross C, et al. Among authors: white ar. Neuropsychopharmacology. 2022 Aug;47(9):1733. doi: 10.1038/s41386-022-01345-x. Neuropsychopharmacology. 2022. PMID: 35701551 Free PMC article. No abstract available.
320 results